Global Diabetes Care Devices Market Forecast to 2030
Emergen Research has recently added a new report titled Global Diabetes Care Devices Market that provides an extensive analysis of the Diabetes Care Devices market and industry overview with regards to market size, market share, revenue growth, key companies, current and emerging market trends, recent technological and product developments, and a comprehensive analysis of the impact of COVID-19 pandemic on the growth of the Diabetes Care Devices market. The report aims to offer a clear understanding of the market with respect to the manufacturers, suppliers, vendors, distributors, and key companies involved in the market. The report has been formulated through extensive primary and secondary research along with verified and reliable data obtained from industry experts and professionals. The key findings from the report have been sorted into charts, figures, tables, and other pictorial representations.
The diabetes care devices market is a rapidly growing segment of the healthcare industry. Diabetes is a chronic disease that affects millions of people worldwide, and diabetes care devices are medical devices used to manage and monitor blood glucose levels in diabetic patients. The global diabetes care devices market size reached USD 22.85 Billion in 2022 and is expected to register a steady revenue CAGR of 6.50% during the forecast period, according to latest analysis by Emergen Research.
One of the major drivers of the diabetes care devices market is the increasing prevalence of diabetes. According to the International Diabetes Federation, approximately 463 million adults were living with diabetes worldwide in 2019, and this number is expected to rise to 700 million by 2045. This has led to a growing demand for diabetes care devices, particularly blood glucose monitoring devices, insulin delivery devices, and other diabetes care accessories.
Another driver of the diabetes care devices market is the increasing adoption of digital diabetes care devices. Manufacturers are developing more advanced diabetes care devices that use digital technology to improve the accuracy and convenience of blood glucose monitoring and insulin delivery. For example, continuous glucose monitoring (CGM) devices can provide real-time glucose readings and alerts to help diabetic patients manage their blood glucose levels more effectively.
According to the World Health Organization, diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation worldwide. In 2019, diabetes was the seventh leading cause of death worldwide.
In the United States, the Centers for Disease Control and Prevention estimates that approximately 34.2 million people, or 10.5% of the population, have diabetes. Approximately 88 million adults, or one in three adults, have prediabetes.
In Europe, the International Diabetes Federation estimates that approximately 59 million adults have diabetes, and this number is expected to rise to 68 million by 2045.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/1897
Research Report on the Diabetes Care Devices Market Addresses the Following Key Questions:
- Who are the dominant players of the Diabetes Care Devices market?
- Which regional market is anticipated to have a high growth rate over the projected period?
- What consumer trends and demands are expected to influence the operations of the market players in the Diabetes Care Devices market?
- What are the key growth drivers and restraining factors of the Diabetes Care Devices market?
- What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
- What is the overall impact of the COVID-19 pandemic on the Diabetes Care Devices market and its key segments?
Market Overview:
The report bifurcates the Diabetes Care Devices market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Type Outlook (Revenue, USD Billion; 2019-2032)
- Blood Glucose Monitoring Systems
- Lancets
- Test Strips/Test Papers
- Insulin Delivery Devices
- Diabetes Management Mobile Applications
Patient Care Settings Outlook (Revenue, USD Billion; 2019-2032)
- Hospitals & Clinics
- Self/Home Healthcare
- Diabetes Specialty Clinics
- Other End-use
Regional Outlook (Revenue, USD Billion; 2019–2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of Middle East & Africa
- North America
Request a discount on the report @ https://www.emergenresearch.com/request-discount/1897
Regional Landscape section of the Diabetes Care Devices report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/diabetes-care-devices-market
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Diabetes Care Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
Key Companies Profiled in the Report are:
Sanofi, Lilly, Medtronic, Ypsomed AG, Procter & Gamble, F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, Insulet Corporation, Abbott, BD
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1897
Thank you for reading our report. To know more about the customization feature, please get in touch with us, and our team will ensure the report is customized to meet your requirements.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
